- ECHA
- Consultări
- Consultări specifice privind clasificarea și etichetarea armonizată
- Harmonised classification and labelling previous targeted consultations
Harmonised classification and labelling previous targeted consultations
Harmonised classification and labelling previous targeted consultations
These targeted consultations for CLH proposals are closed. The consultations are launched in case further information is needed on a particular hazard class, or if comments are sought on e.g. a specific additional document.
The comments received during the consultation are available on the Registry of CLH intentions until outcome.
There are currently no ongoing consultations.
Sunt afişate 1 - 25 rezultate din 40.
N-carboxymethyliminobis(ethylenenitrilo)tetra(acetic acid); Pentapotassium 2,2',2'',2''',2''''-(ethane-1,2-diylnitrilo)pentaacetate; Pentasodium (carboxylatomethyl)iminobis(ethylenenitrilo)tetraacetate |
200-652-8 404-290-3 205-391-3 |
67-43-6 7216-95-7 140-01-2 |
Commission | Details | |||
3-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate | 259-627-5 | 55406-53-6 | 616-212-00-7 | Denmark |
Acute Tox. 3, H331 Acute Tox. 4, H302, STOT RE 1, H372 (larynx) Eye Dam. 1, H318, Skin Sens. 1, H317, Aquatic Acute 1, H400, M = 10, Aquatic Chronic 1, H410, M = 1 |
Acute Tox. 2, H330, Acute Tox. 4, H302, STOT RE 1, H372 (larynx) Eye Dam. 1, H318, Skin Sens. 1, H317, Aquatic Acute 1, H400, M = 10, Aquatic Chronic 1, H410, M = 10 |
Details |
Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, hydrolysis products with silica | 272-697-1 | 68909-20-6 | 014-052-00-7 | Article 77(3) request | STOT RE 2, H373 (lungs, inhalation) |
Acute Tox. 2, H330 STOT RE 2, H373 (lungs, inhalation) inhalation: ATE = 0,45 mg/L |
Details |
pyrithione zinc; (T-4)-bis[1-(hydroxy-.kappa.O)pyridine-2(1H)-thionato-.kappa.S]zinc | 236-671-3 | 13463-41-7 | Sweden |
Acute Tox. 3, H301, Acute Tox. 2, H330, Eye Dam. 1, H318, Repr. 1B, H360D, STOT RE 1, H372, Aquatic Acute 1, H400, M-factor=1000, Aquatic Chronic 1, H410, M-factor=10 |
Details | ||
butanone oxime; ethyl methyl ketoxime; ethyl methyl ketone oxime | 202-496-6 | 96-29-7 | Germany |
Acute Tox. 4*, H312, Eye Dam. 1, H318, Skin Sens. 1, H317, Carc. 2, H351 |
Acute Tox. 3, H301, Acute Tox. 4, H312, Eye Dam. 1, H318, Skin Sens. 1B, H317, Carc. 1B, H350, STOT SE 3, H336 dermal: ATE = 1848 mg/kg oral: ATE = 100 mg/kg |
Details | |
pyrithione zinc; (T-4)-bis[1-(hydroxy-.kappa.O)pyridine-2(1H)-thionato-.kappa.S]zinc | 236-671-3 | 13463-41-7 | Sweden |
Acute Tox. 3, H301 Acute Tox. 2, H330 Eye Dam. 1, H318 Repr. 1B, H360D STOT RE 1, H372 Aquatic Acute 1, H400 Aquatic Acute 1, M-factor=1000 Aquatic Chronic 1, H410 Aquatic Chronic 1, M-factor=10 |
Details | ||
2-butoxyethanol; ethylene glycol monobutyl ether | 203-905-0 | 111-76-2 | 603-014-00-0 | Article 77(3) request |
Acute Tox. 4*; H332 Acute Tox. 4*; H312 Acute Tox. 4*; H302 Skin Irrit. 2; H315 Eye Irrit. 2; H319 |
Acute Tox. 3; H331 Acute Tox. 4; H302 Skin Irrit. 2; H315 Eye Irrit. 2; H319 inhalation: ATE = 3 mg/L oral: ATE = 1200 mg/kg bw |
Details |
cypermethrin (ISO); α-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; cypermethrin cis/trans +/- 40/60 | 257-842-9 | 52315-07-8 | 607-421-00-4 | Belgium |
Acute Tox. 4*, H332 Acute Tox. 4*, H302 STOT SE 3, H335 Aquatic Acute 1, H400 Aquatic Chronic 1, H410 |
Acute Tox. 4*, H332 Acute Tox. 4*, H302 STOT SE 3, H335 Aquatic Acute 1, H400 (M=100000) Aquatic Chronic 1, H410 (M=1000) |
Details |
Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with hydrocarbon solvents and Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with supercritical carbon dioxide | 289-699-3 | 89997-63-7 | Spain |
Acute Tox. 4, H302, Acute Tox. 4, H332, Skin Sens. 1B, H317, Aquatic Acute 1, H400, M-factor=100, Aquatic Chronic 1, H410, M-factor=10 ATE oral = 700 mg/kg bw ATE inhalation = 2.5 mg/L (dusts and mists) |
Details | ||
clomazone (ISO); 2-(2-chlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one | 617-258-0 | 81777-89-1 | Denmark |
Acute Tox. 4, H302, Acute Tox. 4, H332, Repr. 1B, H360D, Aquatic Acute 1, H400, Aquatic Acute 1, M-factor=1, Aquatic Chronic 1, H410, Aquatic Chronic 1, M-factor=1 |
Details | ||
MCPA-thioethyl (ISO); S-ethyl (4-chloro-2-methylphenoxy)ethanethioate; S-ethyl 4-chloro-o-tolyloxythioacetate | 246-831-4 | 25319-90-8 | 246-831-4 | Poland |
Acute Tox. 4, H302, Aquatic Acute 1, M-factor=10, Aquatic Chronic 1, M-factor=10 |
Details | |
N(1,3-dimethylbutyl)-N'-phenyl-p-phenylenediamine | 212-344-0 | 793-24-8 | Austria |
Acute Tox. 4, H302, Skin Sens. 1A, H317, Repr. 1B, H360FD, Aquatic Acute 1, H400, M-factor=10 000, Aquatic Chronic 1, H410, M-factor=10 Oral: ATE = 890 mg/kg bw |
Details | ||
metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one | 244-209-7 | 21087-64-9 | 606-034-00-8 | Estonia |
Acute Tox. 4*, H302, Aquatic Acute 1, H400, Aquatic Acute 1, M-factor=10, Aquatic Chronic 1, H410, Aquatic Chronic 1 |
Acute Tox. 4, H302, STOT RE 2, H373, Aquatic Acute 1, H400, Aquatic Acute 1, M-factor=10, Aquatic Chronic 1, H410, Aquatic Chronic 1, M-factor=100 ATE 322 mg/kg bw |
Details |
transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl (1R,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | 405-060-5 | 118712-89-3 | 607-223-00-8 | Netherlands |
Skin Irrit. 2, H315 Aquatic Acute 1, H400 Aquatic Chronic 1, H410 |
Acute Tox. 4, H302 Carc. 2, H351 STOT SE 1, H370 STOT RE 2, H373 Aquatic Acute 1, H400, M-factor=1000 Aquatic Chronic 1, H410, M-factor=1000 oral: ATE = 583 mg/kg bw |
Details |
N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide; isoflucypram | - | 1255734-28-1 | United Kingdom |
Acute Tox. 4, H332, Skin Sens. 1B, H317, Aquatic Acute 1, H400, Aquatic Acute 1, M-factor=10, Aquatic Chronic 1, H410, Aquatic Chronic 1, M-factor=1 ATE = 2.2 mg/L |
Details | ||
prothioconazole (ISO); 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione | - | 178928-70-6 | United Kingdom |
Aquatic Acute 1, H400, Aquatic Chronic 1, H410 |
Details | ||
diflufenican (ISO); N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide | 617-446-2 | 83164-33-4 | 616-032-00-9 | United Kingdom | Aquatic Chronic 3, H412 |
Aquatic Acute 1, H400 Aquatic Chronic 1, H410 |
Details |
hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate; hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate | 443-860-6 | 302776-68-7 | 607-693-00-4 | Germany | Aquatic Chronic 4, H413 | Aquatic Chronic 1, H410, M-factor = 1000 | Details |
daminozide (ISO); 4-(2,2-dimethylhydrazino)-4-oxobutanoic acid; N-dimethylaminosuccinamic acid | 216-485-9 | 1596-84-5 | Czech Republic | Carc. 1B, H350 | Details | ||
metyltetraprole (ISO); 1-[2-({[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}methyl)-3-methylphenyl]-4-methyl-1,4-dihydro-5H-tetrazol-5-one | - | 1472649-01-6 | France |
Carc. 2, H351, Aquatic Acute 1, H400, M = 10, Aquatic Chronic 1, H410, M = 1 |
Details | ||
(RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy}ethyl methyl carbonate; tolpyralate | - | 1101132-67-5 | United Kingdom |
Carc. 2, H351 STOT RE 2, H373 Aquatic Acute 1, H400, M = 10 Aquatic Chronic 1, H410, M=100 |
Details | ||
S-metolachlor (ISO); 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide; (RaSa)-2-chloro-N-(6-ethyl-o-tolyl)-N-[(1S)-2-methoxy-1-methylethyl]acetamide [contains 80-100 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide and 0-20 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2R)-1-methoxypropan-2-yl]acetamide] | - | 87392-12-9 | 607-432-00-4 | Germany |
Skin Sens. 1; H317 Aquatic Acute 1; H400 Aquatic Chronic 1; H410 |
Carc. 2; H351 Repr. 2; H361d STOT RE 2; H373 (skin) Skin Sens. 1; H317 Aquatic Acute 1 H400 (M=10) Aquatic Chronic 1 H410 (M=10) |
Details |
Glyphosate | 213-997-4 | 1071-83-6 | 607-315-00-8 | Sweden |
Eye Dam. 1, H318, Aquatic Chronic 2, H411 |
Eye Dam. 1, H318, Aquatic Chronic 2, H411 |
Details |
methyl methacrylate; methyl 2-methylprop-2-enoate; methyl 2-methylpropenoate | 201-297-1 | 80-62-6 | 607-035-00-6 | Article 77(3) request |
Flam. Liq. 2, H225 Skin Irrit. 2, H315 Skin Sens. 1, H317 STOT SE 3, H335 |
Flam. Liq. 2, H225 Resp. Sens. 1, H 334 Skin Irrit. 2, H315 Skin Sens. 1, H317 STOT SE 3, H335 |
Details |
methyl methacrylate methyl 2-methylprop-2-enoate methyl 2-methylpropenoate | 201-297-1 | 80-62-6 | 607-035-00-6 | France |
Flam. Liq. 2, H225 Skin Irrit. 2, H315 Skin Sens. 1, H317 STOT SE 3, H335 |
Flam. Liq. 2, H225 Skin Irrit. 2, H315 Resp. Sens. 1, H334 Skin Sens. 1, H317 STOT SE 3, H335 |
Details |
Sunt afişate 1 - 25 rezultate din 40.